ArQule, Inc. · Woburn, MA United States (NASDAQ: ARQL)
| 19 Presidential Way | Phone: 781-994-0300 |
| Woburn, MA | Fax: 781-376-6019 |
| 01801 | |
| United States | 
Map This Company |
ArQule, Inc. Rankings
| S&P 600 |
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
ArQule is pursuing a drug research major in molecular biology, with a focus on cancer cell termination. The biotechnology firm works independently and with other drugmakers to discover new potential drug compounds based on its cancer-inhibiting technology platform. ArQule is developing a portfolio of oncology drugs, with a handful of anti-cancer compounds undergoing clinical trials. It is testing its most advanced candidate, ARQ 197, as a treatment for a variety of tumor types such as non-small cell lung cancer and colorectal cancer through a partnership with
ArQule, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ARQL Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 115 |
Executives
24 executives listed for ArQule, Inc.'s Woburn, MA location.
| Chairman | Patrick Zenner | |
|---|---|---|
| CEO and Director | Paolo Pucci | |
| President, COO, General Counsel, and Secretary | Peter Lawrence |